Back
Innate Pharma SA Vs. Genfit SA Industry Stock Comparison
Sell
7
IPHA
Innate Pharma SA
Last Price:
1.45
Seasonality Move:
6.04%
Sell
42
GNFT
Genfit SA
Last Price:
4.44
Seasonality Move:
16.07%
Sell
7
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.45. The Score for IPHA is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Genfit SA (GNFT)
is a Sell
Is Genfit SA a Buy, Sell or Hold?
- The current Genfit SA [GNFT] share price is $4.26. The Score for GNFT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- GNFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 36.87 | Sell |
| Chaikin Money Flow: | -69244 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 1.92) | Sell |
| Bollinger Bands (100): | (1.86 - 2.3) | Sell |
GNFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 28.42 | Sell |
| Chaikin Money Flow: | -20379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.56 - 5.82) | Sell |
| Bollinger Bands (100): | (4.05 - 5.45) | Sell |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.57 | Sell |
| 20-day SMA: | 1.74 | Sell |
| 50-day SMA: | 1.95 | Sell |
| 200-day SMA: | 2.3 | Sell |
| 8-day EMA: | 1.61 | Sell |
| 20-day EMA: | 1.72 | Sell |
| 50-day EMA: | 1.89 | Sell |
| 200-day EMA: | 2.23 | Sell |
GNFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.33 | Sell |
| 20-day SMA: | 5.07 | Sell |
| 50-day SMA: | 5.28 | Sell |
| 200-day SMA: | 4.33 | Sell |
| 8-day EMA: | 4.43 | Sell |
| 20-day EMA: | 4.86 | Sell |
| 50-day EMA: | 5.03 | Sell |
| 200-day EMA: | 4.5 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Genfit SA Earnings Growth & GNFT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $1.47 per share.
Innate Pharma SA Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Genfit SA Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||